Role of intestinal microbiota in transplantation outcomes
Por:
Taur Y, Jenq RR, Ubeda C, van den Brink M and Pamer EG
Publicada:
1 jun 2015
Ahead of Print:
22 oct 2015
Resumen:
While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area. (C) 2015 Elsevier Ltd. All rights reserved.
Filiaciones:
Taur Y:
Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Weill Cornell Medical College, New York
Jenq RR:
Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Weill Cornell Medical College, New York
:
Centro Superior de Investigacion en Salud Publica-FISABIO, Valencia, Spain
van den Brink M:
Division of Hematologic Oncology, Alan N. Houghton Chair, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Weill Cornell Medical College, New York
Pamer EG:
Weill Cornell Medical College, New York
Division of General Medicine, Chief, Infectious Diseases Service, Enid A. Haupt Chair in Clinical Investigation, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Green Accepted
|